Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,546,000 | 9,755,000 | 8,449,000 | 7,890,000 | 6,017,000 |
| Marketable Securities | 54,000 | 22,000 | 30,000 | 60,000 | 23,000 |
| Receivables | 9,914,000 | 9,588,000 | 8,822,000 | 8,416,000 | 8,354,000 |
| Inventories | 3,386,000 | 3,272,000 | 3,310,000 | 3,474,000 | 4,059,000 |
| TOTAL | $25,999,000 | $26,569,000 | $24,173,000 | $23,009,000 | $21,256,000 |
| Non-Current Assets | |||||
| PPE Net | 5,161,000 | 5,193,000 | 5,248,000 | 4,986,000 | 4,908,000 |
| Investments And Advances | 266,000 | 305,000 | 293,000 | 246,000 | 225,000 |
| Intangibles | 111,738,000 | 113,642,000 | 116,000,000 | 117,444,000 | 119,132,000 |
| Other Non-Current Assets | 4,808,000 | 4,792,000 | 4,851,000 | 3,936,000 | 4,009,000 |
| TOTAL | $121,973,000 | $123,932,000 | $126,392,000 | $126,612,000 | $128,274,000 |
| Total Assets | $147,972,000 | $150,501,000 | $150,565,000 | $149,621,000 | $149,530,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 7,901,000 | 11,347,000 | 8,502,000 | 4,777,000 | 5,371,000 |
| Accounts payable and accrued liabilities | 20,783,000 | 20,604,000 | 20,159,000 | 19,404,000 | 19,275,000 |
| TOTAL | $28,684,000 | $31,951,000 | $28,661,000 | $24,181,000 | $24,646,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 74,237,000 | 74,183,000 | 77,554,000 | 82,282,000 | 82,061,000 |
| Other Non-Current Liabilities | 28,793,000 | 26,864,000 | 27,605,000 | 23,379,000 | 23,307,000 |
| TOTAL | $106,694,000 | $104,817,000 | $108,807,000 | $110,151,000 | $110,152,000 |
| Total Liabilities | $135,378,000 | $136,768,000 | $137,468,000 | $134,332,000 | $134,798,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,767,176 | 1,766,222 | 1,765,882 | 1,765,474 | 1,764,833 |
| Common Shares | 18,000 | 18,000 | 18,000 | 18,000 | 18,000 |
| Retained earnings | 740,000 | 2,292,000 | 1,055,000 | 3,335,000 | 3,130,000 |
| Other shareholders' equity | -3,078,000 | -3,272,000 | -3,096,000 | -3,240,000 | -3,411,000 |
| TOTAL | $12,594,000 | $13,733,000 | $13,097,000 | $15,289,000 | $14,732,000 |
| Total Liabilities And Equity | $147,972,000 | $150,501,000 | $150,565,000 | $149,621,000 | $149,530,000 |